Risk-Based Monitoring in Clinical Trials: Increased Adoption Throughout 2020

With the emergence of new technologies for data collection, the continued impact of the COVID-19 pandemic, and the increasing number of partially or fully decentralized clinical trials (DCTs), the importance of risk-based monitoring (RBM) and the larger risk-based quality management (RBQM) framework...

Descripción completa

Detalles Bibliográficos
Autores principales: Stansbury, Nicole, Barnes, Brian, Adams, Amy, Berlien, Ruth, Branco, Danilo, Brown, Debby, Butler, Paula, Garson, Lauren, Jendrasek, Debra, Manasco, Garrett, Ramirez, Nycole, Sanjuan, Nelly, Worman, Gillian, Adelfio, Anina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Analytical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889871/
https://www.ncbi.nlm.nih.gov/pubmed/35235192
http://dx.doi.org/10.1007/s43441-022-00387-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889871/
https://www.ncbi.nlm.nih.gov/pubmed/35235192
http://dx.doi.org/10.1007/s43441-022-00387-z

Ejemplares similares